Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 04. August 2026
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2231  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 44608  
   
Neural Stem Cells in Multiple Sclerosis: A Comprehensive Review of Preclinical and Clinical Evidence for CNS Repair and Translational Hurdles.
Appl Biochem Biotechnol
Razzaghi E, Azari A, Golchin A, Mihanfar A.
PMID: 42547698 [PubMed - as supplied by publisher]


Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transition.
Nat Rev Neurol
Thompson AJ, Lublin FD, Rechtman L, Quinn J, Amato MP, Bebo B, Calabresi PA, Fiol J, Finlayson M, Hawton A, Kuhlmann T, Marrie RA, Moccia M, Montalban X, Panzara M, Smith K, Sormani MP, Strum J, Vickrey BG, Coetzee T, 2025 International Advisory Committee on Clinical Trials in Multiple Sclerosis.
PMID: 42547548 [PubMed - as supplied by publisher]


A Faster Way to Diagnose Multiple Sclerosis: The Central Vein Sign in Routine Clinical Practice.
Neurol Clin Pract
Gilmartin CGS, Paskin T, Clarke MA, De Dios Peréz B, Morgan P, Dineen RA, Evangelou N.
PMID: 42546228 [PubMed - indexed for MEDLINE]


Dysregulation of ferroptosis-related plasma biomarkers in treatment-free patients with relapsing-remitting multiple sclerosis in clinical remission: a case-control study.
Acta Neurol Belg
Nazari-Robati M, Shahouzehi B, Naiini MR.
PMID: 42545622 [PubMed - as supplied by publisher]


Clinical and economic impact on people with relapsing-remitting multiple sclerosis in the United States: a matched-cohort study.
Curr Med Res Opin
Greene N, Das AK, Hemim I, Chang E, Tarbox MH, Higuchi K.
PMID: 42544916 [PubMed - as supplied by publisher]


Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis.
Mult Scler
Brittain G, Long M, Buckley E, Becker C, Buekers J, de Las Heras M, Armengol C, Koch S, Braun J, Caufield B, Comi G, Dalla Costa G, Frei A, Gassner H, Ionescu A, Leocani L, Rochester L, Rothhammer V, Singleton D, Stuerner KH, Paling D, Padmakumari Sivaraman Nair K, Majid A, Brichetto G, Vereijken B, Lanfranchi V, Jansen CP, Sutcliffe L, Del Din S, Neatrour I, Cereatti A, Maetzler W, Hansen C, Rooks D, Sharrack B, Garcia-Aymerich J.
PMID: 42544006 [PubMed - as supplied by publisher]


Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
Mult Scler
Nesbitt C, Sanfilippo P, Zhu C, Ozakbas S, Prat A, Girard M, Duquette P, Kalincik T, Roos I, Buzzard K, Skibina O, Foschi M, Surcinelli A, Lechner-Scott J, Patti F, Kermode AG, Fabis-Pedrini M, Carroll WM, Hodgkinson S, Grand'Maison F, Havrdova EK, Hradilek P, Habek M, Maimone D, Alroughani R, Vachova M, van Pesch V, Macdonell R, Spitaleri D, Khoury SJ, Gerlach O, de Gans K, McCombe P, Van Der Walt A, Butzkueven H, Jokubaitis V.
PMID: 42543909 [PubMed - as supplied by publisher]


Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials.
Br J Clin Pharmacol
Hamm-Buiar L, Gorski D, Kagueiama MH, Wiens A.
PMID: 42543771 [PubMed - as supplied by publisher]


Incidence and prevalence of multiple sclerosis in Qatar: A population-based study from 2016 to 2024.
Mult Scler Relat Disord
AbuAlrob MA, Khodair R, Ibrahim F, Hamid S, Suliman O, Zammar K, Abdelmoneim MS, Perkins JD, Canibano B.
PMID: 42542074 [PubMed - as supplied by publisher]


Impact of tobacco and alcohol consumption on disease progression and MRI in people with multiple sclerosis: results of the prospective cohort study NationMS.
Ther Adv Neurol Disord
Keller AM, Möhl A, Salmen A, Gold R, Renk P, Klotz L, Bittner S, Fleischer V, Paul F, Ruprecht K, Giglhuber K, Tumani H, Antony G, Zettl U, Meuth SG, Bayas A, Trebst C, Wildemann B, Then Bergh F, Kotz D, Heesen C.
PMID: 42539872 [PubMed]


Predictors of Multiple Sclerosis After Clinically Isolated Syndrome: A Systematic Review and Meta-Analysis.
Eur J Neurol
Zafra-Sierra MP, Ferreira-Atuesta C, Rodríguez DS, Gaitán J, Otero S, Tintoré M, Lublin F, Giovannoni G, Toro J, Reyes S.
PMID: 42538767 [PubMed - indexed for MEDLINE]


Lesion burden determines the incremental diagnostic value of intrathecal IgG oligoclonal bands synthesis in multiple sclerosis.
J Neuroimmunol
Mauceri VA, Di Mare D, Rinaldi F, Di Paola A, Zoccarato M, Gallo P, Perini P, Puthenparampil M.
PMID: 42537512 [PubMed - as supplied by publisher]


MSPEECH (multiple sclerosis monitoring through speech interaction in clinic and at home): a Living Lab study protocol for co-created, speech-based digital biomarkers in multiple sclerosis.
Front Digit Health
Lemkau T, Inojosa H, Dillenseger A, Tröger J, Hermann J, Linz N, Gilbert S, Ziemssen T.
PMID: 42534930 [PubMed]


Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study.
Front Neurol
Nourelden AZ, Scott PR, Hooshmand SI, Mazur I, Mada F, Ash T, Patel N, Rube J, Yarraguntla K, Deluca C, Yager-Stone P, Havens R, Wallin M, Memon AB.
PMID: 42534927 [PubMed]


Early Upper Limb Motor Impairment in Multiple Sclerosis Across EDSS Levels: A Case-Control Study.
Brain Behav
Blázquez-Fernández A, Marcos-Antón S, Estrada-Barranco C, Martín-Casas P, Ortiz-Gutiérrez RM, Jiménez-Antona C, Laguarta-Val S, Cano-de-la-Cuerda R.
PMID: 42533673 [PubMed - indexed for MEDLINE]


Comorbidities in multiple sclerosis: acquired hepatocerebral degeneration mimicking disease progression.
Neurol Sci
Einsiedler M, Polymeris A, Raptis N, Beyer A, Becker D, Krassenburg L, Panne I, Mahmutoglu MA, Lieb JM, Rüegg S, Derfuss T, Kuhle J.
PMID: 42533190 [PubMed - indexed for MEDLINE]


Manual federated simulation for multiple sclerosis integrating XGBoost algorithm with SHAP explanation.
Sci Rep
Ghazy HE, Ali ZH, Medhat T.
PMID: 42533015 [PubMed - indexed for MEDLINE]


Structured exercise training for fatigue management in multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.
Arch Phys Med Rehabil
Rubio-Arias JÁ, Villena-Molina S, Andreu-Carvaca L, Leon-Ariza HH, María Del Carmen FC, Ramos-Campo DJ.
PMID: 42532214 [PubMed - as supplied by publisher]


The impact of multiple sclerosis on social determinants of health: Results from the SocialMS study.
Mult Scler Relat Disord
Ponzano M, Signori A, Schiavetti I, Landi D, Bellavia A, Lavorgna L, Fantozzi R, Buttari F, Di Sapio A, Quartana D, Marinelli F, Tartaglia M, Callari G, Cavalla P, Frau J, Grasso MG, Tsantes E, Buscarinu MC, Marfia GA, Zuliani L, Cordioli C, Sibilia G, Immovilli P, Lorefice L, Lugaresi A, Lanzillo R, Panzera I, Stromillo ML, Mori L, Laroni A, Battaglia MA, Sormani MP, SocialMS study group.
PMID: 42531682 [PubMed - as supplied by publisher]


Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.
Ann Neurol
Amezcua L, Reder AT, Bernitsas E, Monson NL, Vartanian T, Wu GF, Saleh M, Okai A, Obeidat AZ, Sokhi D, Parekh R, Pei J, Harp C, Clayton D, Abioye I, Williams MJ, CHIMES Study Group.
PMID: 42530333 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 44608    Seite 1 von 2231  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1